Naturally presented HLA class l–restricted epitopes from the neurotrophic factor S100‐β are targets of the autoimmune response in type 1 diabetes

Abstract

Type 1 diabetes (T1D) results from the destruction of pancreatic β-cells by the immune system, and CD8 + T lymphocytes are critical actors in this autoimmune response. Pancreatic islets are surrounded by a mesh of nervous cells, the peri-insular Schwann cells, which are also targeted by autoreactive T lymphocytes and express specific antigens, such as the neurotrophic factor S100-β. Previous work has shown increased proliferative responses to whole S100-β in both human T1D patients and the nonobese diabetic (NOD) mouse model. We describe for the first time naturally processed and presented epitopes (NPPEs) presented by class I human leukocyte antigen–A*02:01 (A2.1) molecules derived from S100-β. These NPPEs triggered IFN-γ responses more frequently in both newly diagnosed and long-term T1D patients compared with healthy donors. Furthermore, the same NPPEs are recognized during the autoimmune response leading to diabetes in A2.1-transgenic NOD mice as early as 4 wk of age. Interestingly, when these NPPEs are used to prevent diabetes in this animal model, an acceleration of the disease is observed together with an exacerbation in insulitis and an increase in S100-β–specific cytotoxicity in vaccinated animals. Whether these can be used in diabetes prevention needs to be carefully evaluated in animal models before use in future clinical assays.—Calviño-Sampedro, C., Gomez-Tourino, I., Cordero, O. J., Reche, P. A., Gómez-Perosanz, M., Sánchez-Trincado, J. L., Rodríguez, M. Á., Sueiro, A. M., Viñuela, J. E., Calviño, R. V. Naturally presented HLA class I–restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes.

Immune disorder in endometrial cancer: Immunosuppressive microenvironment, mechanisms of immune evasion and immunotherapy (Review)

“…The HLA class I system serves an important role in the tumor immune response. This system comprises the classical HLA-A, -B and -C antigens, and the non-classical HLA-E, -F and -G antigens ( 60 ). Cancer cells can escape the CTL response by inhibiting HLA class I molecules ( 61 , 62 ).…”

Screening of breast cancer diagnostic and prognostic biomarkers using bioinformatics analysis

“…The full name of S100B gene is S100 calcium binding protein B. S100 protein is localized in the cytoplasm and/or nucleus of various cells and is involved in the regulation of many cellular processes, such as cell cycle progression and differentiation. Chromosomal rearrangements and altered expression of this gene have been linked to several neurological, neoplastic and other types of diseases, including Alzheimer's disease [9],Down syndrome [10],epilepsy [11],amyotrophic lateral sclerosis [12],melanoma [13]and type 1 diabetes [14] etc. Relevant studies have shown that S100B is associated with breast cancer prognosis, and high S100B expression predicts that breast cancer patients have a good long-distance metastasisfree survival [15],which is consistent with our analysis results.…”

The many faces of islet antigen‐specific CD8 T cells: clues to clinical outcome in type 1 diabetes

“…Peripheral blood CD8 T cells responding to pancreatic antigens have been reported in both T1D patients and healthy controls. With the use of stimulation assays, the quantity of islet antigen-specific CD8 T cells is nearly universally reported to be greater in T1D patients than in healthy controls, 16,[23][24][25][26][27][28][29][30][31][32][33][34] and this extends to at-risk autoantibodypositive first-degree relatives 23,26 (Table 1). By contrast, by peptide-MHC multimer assays, which do not require functionality of a cell for its detection, the results are mixed.…”